Assistant Professor, Medicine, UCSD School of Medicine
Gastroenterology
Dr. Bernd G. Schnabl, MD
|
|
Give Review
Bernd G. Schnabl, MD works in the field of Gastroenterology. Bernd Schnabl is also published. He has 62 publications published. The lastest publication: "Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models.'
Publications
- Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to Systemic inflammation hypothesis.
- Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis.
- Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance.
- Methods to determine Intestinal permeability and bacterial translocation during liver disease.
- Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.
- Dysbiosis-induced Intestinal inflammation activates TNFRI and mediates alcoholic liver disease in mice.
- Effect of Weight Loss on MRI Estimation of Liver Fat and Volume in Patients With Nonalcoholic Steatohepatitis.
- Supplementation of Saturated Long-chain Fatty Acids Maintains Intestinal Eubiosis and Reduces Ethanol-induced Liver Injury in Mice.
- Host-Microbiome Interactions in Alcoholic Liver Disease.
- Nod2 deficiency protects mice from cholestatic liver Disease by increasing renal excretion of bile acids.
- Interactions Between the Intestinal Microbiome and Liver Diseases.
- Transplanting a fibrogenic microbiota.
- Linking Intestinal homeostasis and liver disease.
- Deficiency of Intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice.
- Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.
- The Intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease.
- Toll-Like Receptor 2-Mediated Intestinal Injury and Enteric Tumor Necrosis Factor Receptor I Contribute to Liver Fibrosis in Mice.
- Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis.
- Origin of myofibroblasts in liver fibrosis.
- Bacterial translocation and changes in the Intestinal microbiome in mouse models of liver disease.
- Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist.
- CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
- The role of Smad3 in mediating mouse hepatic stellate cell activation.
- TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells.
- Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy.
- Immortal activated human hepatic stellate cells generated by ectopic telomerase expression.
- Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype.
- Gliotoxin-mediated apoptosis of activated human hepatic stellate cells.
- TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesis.
- LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors.
- Characterization of the human zinc finger protein 267 promoter: essential role of nuclear factor Y.
- Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10.
- DNA microarrays and data mining to study hepatic fibrosis.
- Different effects of a CD14 gene polymorphism on Disease outcome in patients with alcoholic liver Disease and chronic hepatitis C infection.
- Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
- Results of allergen-specific immunotherapy in 117 dogs with atopic dermatitis.
- Bone morphogenetic protein 7 is elevated in patients with chronic liver Disease and exerts fibrogenic effects on human hepatic stellate cells.
- MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against Intestinal Listeria monocytogenes infection.
- Up-regulated eotaxin plasma levels in chronic liver Disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.
- What is the potential role of antifibrotic agents for the treatment of liver Disease?
- Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.
- A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells.
- Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits.
- Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
- Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
- Enhanced sensitivity to DSS Colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response.
- Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
- c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
- Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.
- Oral selamectin in the treatment of canine generalised demodicosis.
- Enteric dysbiosis associated with a mouse model of alcoholic liver Disease.
- CXCL5 plasma levels decrease in patients with chronic liver Disease.
- The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91(phox) mediate hepatic fibrosis in mice.
- X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C.
- Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase.
- Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.
- Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver Disease.
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.
- Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls.
- Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation.
- Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models.
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
Conditions Treated
- Abdominal Pain
- Anemia
- Benign Neoplasm of the Digestive System
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Education
-
New York Presbyterian Hospital -
Albert Ludwigs University Faculty of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Carlton Thomas, MD |
|
|
Dr. Darren B. Keller, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald C. Lipkis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh Pola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles S. Hames, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alissa G. Speziale, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mamie H. Dong, MD |